P30044 (PRDX5_HUMAN) Homo sapiens (Human)
Peroxiredoxin-5, mitochondrial UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
12 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Oxidized form of human peroxiredoxin 5 | homo-4-mer | |||||
Assess | ||||||
wild type human PrxV with DTT bound as a competitive inhibitor | homo-2-mer | 2×D1D; 16×BR; 4×GOL; | ||||
Assess | ||||||
Human peroxiredoxin 5 | homo-2-mer | 2×BEZ; 10×BR; | ||||
Assess | ||||||
Oxidized and reduced forms of human peroxiredoxin 5 | homo-2-mer | |||||
Assess | ||||||
Oxidized and reduced forms of human peroxiredoxin 5 | homo-2-mer | 2×BEZ; | ||||
Assess | ||||||
HUMAN PEROXIREDOXIN 5 with a fragment | homo-2-mer | 2×MCT; | ||||
Assess | ||||||
Human Pdrx5 complex with a ligand BP7 | monomer | 1×BP7; | ||||
Assess | ||||||
HUMAN PEROXIREDOXIN 5, C47S MUTANT | monomer | 1×BEZ; 3×CL; | ||||
Assess | ||||||
Monoclinic form of human peroxiredoxin 5 | monomer | 1×BEZ; | ||||
Assess | ||||||
HUMAN PEROXIREDOXIN 5 with a fragment | monomer | 1×EKZ; 1×DMS; | ||||
Assess | ||||||
HUMAN PEROXIREDOXIN 5 | monomer | 1×BEZ; | ||||
Assess | ||||||
HUMAN PEROXIREDOXIN 5 with a fragment | monomer | 1×CAQ; 1×DMS; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
2vl2.2.A | homo-2-mer | 0.85 | 1×BEZ; | 97.58 | ||
Assess |
4 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 2vl2.2.A | homo-2-mer | 0.85 | 1×BEZ; | 99.38 | |
Assess | ||||||
Isoform 3 | 2vl2.2.A | homo-2-mer | 0.76 | 1×BEZ; | 95.87 | |
Assess | ||||||
Isoform 3 | 1oc3.3.A | monomer | 0.67 | 95.87 | ||
Assess | ||||||
Isoform 4 | 1urm.1.A | monomer | 0.53 | 90.36 | ||
Assess |